An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

HB 2158 amends Pennsylvania's Controlled Substance Act by adding specific kratom-related compounds to Schedule I, the most restrictive category for controlled substances. The bill prohibits possession, sale, or distribution of any product containing 7-hydroxymitragynine at 2% or more of total alkaloids, or synthetic versions of kratom alkaloids like mitragynine. This change directly affects businesses selling kratom products and individuals who use such substances, making them illegal without medical authorization. The policy change aligns with existing Schedule I criteria of high abuse potential and no accepted medical use.